Reviews in
Neuro-Oncology


Volume 21 Number 5
May 2019


Home > Disciplines > Publications > Reviews on Neuro-Oncology > Volume 21, Year 2019 > Number 5, May


CONTENTS


CENTRAL NERVOUS SYSTEM TUMORS

GLIOMAS
BRAIN STEM GLIOMAS
DIFFUSE MIDLINE GLIOMAS
HIGH-GRADE GLIOMAS
GLIOMATOSIS CEREBRI
LOW-GRADE GLIOMAS

DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS
GLIOBLASTOMA

EMBRYONAL TUMORS
MEDULLOBLASTOMA

GERM CELL TUMORS





CENTRAL NERVOUS SYSTEM TUMORS

.

Godlewski J, Lenart J, Salinska E.
MicroRNA in Brain pathology: Neurodegeneration the Other Side of the Brain Cancer.
Noncoding RNA. 2019 Feb 23;5(1). pii: E20. doi: 10.3390/ncrna5010020.
Source | Full text | Similar articles



.

Ma Q, Xing C, Long W, Wang HY, Liu Q, Wang RF.
Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis.
J Neuroinflammation. 2019 Mar 1;16(1):53. doi: 10.1186/s12974-019-1434-3.
Source | Full text | Similar articles



.

Pollack IF, Agnihotri S, Broniscer A.
Childhood brain tumors: current management, biological insights, and future directions.
J Neurosurg Pediatr. 2019 Mar 1;23(3):261-273. doi: 10.3171/2018.10.PEDS18377.
Source | Full text | Similar articles



.

Song Y, Wang Z, Jin Y, Guo J.
Association between tea and coffee consumption and brain cancer risk: an updated meta-analysis.
World J Surg Oncol. 2019 Mar 15;17(1):51. doi: 10.1186/s12957-019-1591-y.
Source | Full text | Similar articles



GLIOMAS

.

Alarcón S, Niechi I, Toledo F, Sobrevia L, Quezada C.
Glioma progression in diabesity.
Mol Aspects Med. 2019 Mar 4. pii: S0098-2997(18)30083-9. doi: 10.1016/j.mam.2019.02.002. [Epub ahead of print]
Source | Full text | Similar articles



.

Farias KPRA, Moreli ML, Floriano VG, da Costa VG.
Evidence based on a meta-analysis of human cytomegalovirus infection in glioma.
Arch Virol. 2019 May;164(5):1249-1257. doi: 10.1007/s00705-019-04206-z. Epub 2019 Mar 19.
Source | Full text | Similar articles



BRAIN STEM GLIOMAS


.

Yu D, Han G, Liu H, Gao L, Verma V.
Treatment of adult brainstem glioma with combined antiangiogenic therapy: a case report and literature review.
Onco Targets Ther. 2019 Feb 18;12:1333-1339. doi: 10.2147/OTT.S195783. eCollection 2019.
Source | Full text | Similar articles



DIFFUSE MIDLINE GLIOMAS


.

Lu VM, Welby JP, Mahajan A, Laack NN, Daniels DJ.
Reirradiation for diffuse intrinsic pontine glioma: a systematic review and meta-analysis.
Childs Nerv Syst. 2019 May;35(5):739-746. doi: 10.1007/s00381-019-04118-y. Epub 2019 Mar 16.
Source | Full text | Similar articles



.

Welby JP, Kaptzan T, Wohl A, Peterson TE, Raghunathan A, Brown DA, Gupta SK, Zhang L, Daniels DJ.
Current Murine Models and New Developments in H3K27M Diffuse Midline Gliomas.
Front Oncol. 2019 Feb 27;9:92. doi: 10.3389/fonc.2019.00092. eCollection 2019.
Source | Full text | Similar articles



HIGH-GRADE GLIOMAS




GLIOMATOSIS CEREBRI


.

Georgakis MK, Tsivgoulis G, Pourtsidis A, Petridou ET.
Gliomatosis Cerebri Among Children and Adolescents: An Individual-Patient Data Meta-analysis of 182 Patients.
J Child Neurol. 2019 Mar 19:883073819836551. doi: 10.1177/0883073819836551. [Epub ahead of print]
Source | Full text | Similar articles



LOW-GRADE GLIOMAS


.

Carabenciov ID, Buckner JC.
Controversies in the Therapy of Low-Grade Gliomas.
Curr Treat Options Oncol. 2019 Mar 14;20(4):25. doi: 10.1007/s11864-019-0625-6.
Source | Full text | Similar articles



DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS

.

Santosh V, Sravya P, Gupta T, Muzumdar D, Chacko G, Suri V, Epari S, Balasubramaniam A, Radotra BD, Chatterjee S, Sarkar C, Jalali R.
ISNO consensus guidelines for practical adaptation of the WHO 2016 classification of adult diffuse gliomas.
Neurol India. 2019 Jan-Feb;67(1):173-182. doi: 10.4103/0028-3886.253572. Date of Web Publication: 7-Mar-2019.
Source | Full text | Similar articles



GLIOBLASTOMA


.

Caccese M, Indraccolo S, Zagonel V, Lombardi G.
PD-1/PD-L1 immune-checkpoint inhibitors in glioblastoma: A concise review.
Crit Rev Oncol Hematol. 2019 Mar;135:128-134. doi: 10.1016/j.critrevonc.2018.12.002. Epub 2019 Feb 1.
Source | Full text | Similar articles



.

Chua J, Nafziger E, Leung D.
Evidence-Based Practice: Temozolomide Beyond Glioblastoma.
Curr Oncol Rep. 2019 Mar 5;21(4):30. doi: 10.1007/s11912-019-0783-5.
Source | Full text | Similar articles



.

Finocchiaro G, Pellegatta S.
NG2/CSPG4 in glioblastoma: about flexibility.
Neuro Oncol. 2019 Mar 28. pii: noz055. doi: 10.1093/neuonc/noz055. [Epub ahead of print]
Source | Full text | Similar articles
Comment on:
Al-Mayhani T et al.,A Non-Hierarchical Organisation of Tumorigenic NG2 Cells in Glioblastoma promoted by EGFR.
Neuro Oncol. 2018 Dec 22. doi: 10.1093/neuonc/noy204. [Epub ahead of print].
Source / Full text



.

Lukas RV, Wainwright DA, Ladomersky E, Sachdev S, Sonabend AM, Stupp R.
Newly Diagnosed Glioblastoma: A Review on Clinical Management.
Oncology (Williston Park). 2019 Mar 13;33(3):91-100.
Source | Full text | Similar articles



.

Mistry AM.
On the subventricular zone origin of human glioblastoma.
Transl Cancer Res. 2019 Feb;8(1):11-13. doi: 10.21037/tcr.2018.11.31.
Source | Full text | Similar articles
Comment on:
Lee JH et al., Human glioblastoma arises from subventricular zone cells with low-level driver mutations.
Nature. 2018 Aug;560(7717):243-247. doi: 10.1038/s41586-018-0389-3. Epub 2018 Aug 1.
Source / Full text



.

Perrin SL, Samuel MS, Koszyca B, Brown MP, Ebert LM, Oksdath M, Gomez GA.
Glioblastoma heterogeneity and the tumour microenvironment: implications for preclinical research and development of new treatments.
Biochem Soc Trans. 2019 Mar 22. pii: BST20180444. doi: 10.1042/BST20180444. [Epub ahead of print]
Source | Full text | Similar articles



.

Weller M, Le Rhun E.
Immunotherapy for glioblastoma: quo vadis?
Nat Rev Clin Oncol. 2019 Mar 13. doi: 10.1038/s41571-019-0195-3. [Epub ahead of print]
Source | Full text | Similar articles



.

Zanders ED, Svensson F, Bailey DS.
Therapy for glioblastoma: is it working?
Drug Discov Today. 2019 Mar 13. pii: S1359-6446(18)30188-0. doi: 10.1016/j.drudis.2019.03.008. [Epub ahead of print]
Source | Full text | Similar articles





EMBRYONAL TUMORS



MEDULLOBLASTOMA


.

Menyhárt O, Giangaspero F, Győrffy B.
Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomas.
J Hematol Oncol. 2019 Mar 15;12(1):29. doi: 10.1186/s13045-019-0712-y.
Source | Full text | Similar articles



GERM CELL TUMORS

.

Ritchey AK et al., PDQ Pediatric Treatment Editorial Board.
Childhood Central Nervous System Germ Cell Tumors Treatment (PDQ®): Patient Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2019 Mar 8.
Source | Full text | Similar articles



bottom